Sam Ulin is a Partner at ClearView Healthcare Partners and has broad experience across the full spectrum of strategic innovation and growth engagements in the life sciences arena, ranging from therapeutic growth strategy to asset-level growth strategy and strategic transactional support. He has worked extensively to help companies optimize the development life cycle of innovative technology platforms. In parallel, Dr. Ulin brings to the table intimate knowledge of the global commercial landscape for novel therapeutics, diagnostics and technologies, having done extensive brand planning and go-to-market work across across 30 key emerging and established markets.  Prior to joining ClearView, Dr. Ulin worked in research and product development around life sciences research tools, with a focus on precision genomic approaches and expertise in genetic and cellular therapeutics. Dr. Ulin received his Sc.B. with honors in biochemistry at Brown University before receiving a MS in molecular biology from UCSD.